In addition to influencing the activity of DCs themselves, Tregs may alter DC function; for example, Treg-treated DCs tend to skew CD4+ naïve T cell polarization and impair CD8+ Teffs function in inducing GVHD (70). Here, CD8A is linked to graft versus host disease.